Treatment of mpox with tecovirimat under expanded access use in the Central African Republic
Josephine Bourner, Festus Mbrenga, Elise Pesonel, Aboubacar Soumah, Sandra Garba-Ouangole, Ella Farra, Cyprien Lemon, Christian Malaka, Jake Dunning, Amanda Rojek, Yap Boum, Peter Horby, Emmanuel Nakouné, Piero Olliaro · 2026
Read Treatment of mpox with tecovirimat under expanded access use in the Central African Republic by Josephine Bourner, Festus Mbrenga, Elise Pesonel, Aboubacar Soumah, Sandra Garba-Ouangole, Ella Farra, Cyprien Lemon, Christian Malaka, Jake Dunning, Amanda Rojek, Yap Boum, Peter Horby, Emmanuel Nakouné, Piero Olliaro (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13615899.txt.
Description
Bourner and colleagues reported in 2026 outcomes from an expanded access program that gave the antiviral tecovirimat to patients with clade Ia mpox in the Central African Republic. This clade causes varied illness, and data from the region were scarce. Patients joined late, on average more than two weeks after symptoms began. About a third arrived with general symptoms but no active rash left.
Most patients improved by the end of treatment, with lesions settling in a middle time of about eight days. No serious side effects were blamed on the drug, and the one death in the program was judged unrelated. Virus DNA fell over time but could still be detected past day twenty-eight in some patients. With no comparison group, the authors cannot tell drug effect from the illness fading on its own.
Catalog record
| CREATOR | Josephine Bourner, Festus Mbrenga, Elise Pesonel, Aboubacar Soumah, Sandra Garba-Ouangole, Ella Farra, Cyprien Lemon, Christian Malaka, Jake Dunning, Amanda Rojek, Yap Boum, Peter Horby, Emmanuel Nakouné, Piero Olliaro |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |